Adenosine and inosine increase cutaneous vasopermeability by activating A3 receptors on mast cells

被引:147
作者
Tilley, SL
Wagoner, VA
Salvatore, CA
Jacobson, MA
Koller, BH
机构
[1] Univ N Carolina, Dept Med, Div Pulm & Crit Care Med, Chapel Hill, NC 27599 USA
[2] Merck Res Labs, Dept Pharmacol, W Point, PA 19486 USA
关键词
D O I
10.1172/JCI8253
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Adenosine has potent effects on both the cardiovascular and immune systems. Exposure of tissues to adenosine results in increased vascular permeability and extravasation of serum proteins. The mechanism by which adenosine brings about these physiological changes is poorly defined. Using mice deficient in the Ag adenosine receptor (A(3)AR), we show that increases in cutaneous vascular permeability observed after treatment with adenosine or its principal metabolite inosine are mediated through the A3AR. Adenosine fails to increase vascular permeability in mast cell-deficient mice, suggesting that this tissue response to adenosine is mast cell-dependent. Furthermore, this response is independent of activation of the high-affinity IgE receptor (Fc epsilon R1) by antigen, as adenosine is equally effective in mediating these changes in FceR1 P-chain-deficient mice. Together these results support a model in which adenosine and inosine induce changes in vascular permeability indirectly by activating mast cells, which in turn release vasoactive substances. The demonstration in vivo that adenosine, acting through a specific receptor, can provoke degranulation of this important tissue-based effector cell, independent of antigen activation of the high-affinity IgE receptor, supports an important role for this nucleoside in modifying the inflammatory response.
引用
收藏
页码:361 / 367
页数:7
相关论文
共 46 条
[1]   DIFFERENTIAL VASODILATORY ACTION OF 2-OCTYNYLADENOSINE (YT-146), AN ADENOSINE A(2) RECEPTOR AGONIST, IN THE ISOLATED RAT FEMORAL-ARTERY AND VEIN [J].
ABIRU, T ;
ENDO, K ;
MACHIDA, H .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1995, 281 (01) :9-15
[2]  
ALI H, 1990, J BIOL CHEM, V265, P745
[3]   Canine mast cell adenosine receptors: Cloning and expression of the A(3) receptor and evidence that degranulation is mediated by the A(2B) receptor [J].
Auchampach, JA ;
Jin, XW ;
Wan, TC ;
Caughey, GH ;
Linden, J .
MOLECULAR PHARMACOLOGY, 1997, 52 (05) :846-860
[4]   STUDIES ON THE RECEPTOR MEDIATING CYCLIC AMP-INDEPENDENT ENHANCEMENT BY ADENOSINE OF IGE-DEPENDENT MEDIATOR RELEASE FROM RAT MAST-CELLS [J].
CHURCH, MK ;
HUGHES, PJ ;
VARDEY, CJ .
BRITISH JOURNAL OF PHARMACOLOGY, 1986, 87 (01) :233-242
[5]   THE VASODILATOR ROLE OF ADENOSINE [J].
COLLIS, MG .
PHARMACOLOGY & THERAPEUTICS, 1989, 41 (1-2) :143-162
[6]   Allergy-associated FcRβ is a molecular amplifier of IgE- and lgG-mediated in vivo responses [J].
Dombrowicz, D ;
Lin, SQ ;
Flamand, V ;
Brini, AT ;
Koller, BH ;
Kinet, JP .
IMMUNITY, 1998, 8 (04) :517-529
[7]   ABOLITION OF ANAPHYLAXIS BY TARGETED DISRUPTION OF THE HIGH-AFFINITY IMMUNOGLOBULIN-E RECEPTOR ALPHA-CHAIN GENE [J].
DOMBROWICZ, D ;
FLAMAND, V ;
BRIGMAN, KK ;
KOLLER, BH ;
KINET, JP .
CELL, 1993, 75 (05) :969-976
[8]   NUCLEOSIDE-INDUCED ARTERIOLAR CONSTRICTION - A MAST CELL-DEPENDENT RESPONSE [J].
DOYLE, MP ;
LINDEN, J ;
DULING, BR .
AMERICAN JOURNAL OF PHYSIOLOGY, 1994, 266 (05) :H2042-H2050
[9]  
Elliott J, 1998, J VET PHARMACOL THER, V21, P74, DOI 10.1046/j.1365-2885.1998.00106.x
[10]   ADENOSINE A(2B) RECEPTORS EVOKE INTERLEUKIN-8 SECRETION IN HUMAN MAST-CELLS - AN ENPROFYLLINE-SENSITIVE MECHANISM WITH IMPLICATIONS FOR ASTHMA [J].
FEOKTISTOV, I ;
BIAGGIONI, I .
JOURNAL OF CLINICAL INVESTIGATION, 1995, 96 (04) :1979-1986